Normal tissue complication probability modeling of radiation-induced sensorineural hearing loss after head-and-neck radiation therapy

References

• Adamus-Górka M, Mavroidis P, Lind BK, Brahme A. 2011. Comparison of dose response models for predicting normal tissue complications from cancer radiotherapy: application in rat spinal cord. Cancers (Basel). 3:2421–2443.
   PubMedGoogle Scholar
• Akmansu H, Eryilmaz A, Korkmaz H, Sennaroğlu G, Akmansu M, Göçer C, Tatar İ. 2004. Ultrastructural and electrophysiologic changes of rat cochlea after irradiation. Laryngoscope. 114:1276–1280.
   PubMed Web of Science ®Google Scholar
• Allen Li X, Alber M, Deasy JO, Jackson A, Ken Jee KW, Marks LB, Martel MK, Mayo C, Moiseenko V, Nahum AE. 2012. The use and QA of biologically related models for treatment planning: short report of the TG-166 of the therapy physics committee of the AAPM. Med Phys. 39:1386–1409.
   PubMed Web of Science ®Google Scholar
• Bakhshandeh M, Hashemi B, Mahdavi SRM, Nikoofar A, Vasheghani M, Kazemnejad A. 2013. Normal tissue complication probability modeling of radiation-induced hypothyroidism after head-and-neck radiation therapy. Int J Radiat Oncol Biol Phys. 85:514–521.
   PubMed Web of Science ®Google Scholar
• Bhandare N, Jackson A, Eisbruch A, Pan CC, Flickinger JC, Antonelli P, Mendenhall WM. 2010. Radiation therapy and hearing loss. Int J Radiat Oncol Biol Phys. 76:S50–S57.
   PubMed Web of Science ®Google Scholar
• Burnham KP, Anderson DR, Huyvaert KP. 2011. AIC model selection and multimodel inference in behavioral ecology: some background, observations, and comparisons. Behav Ecol Sociobiol. 65:23–35.
   Web of Science ®Google Scholar
• Chan S, Ng W, Kam K, Lee MC, Choi C, Yau T, Lee AW, Chow S. 2009. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis. Int J Radiat Oncol Biol Phys. 73:1335–1342.
   PubMed Web of Science ®Google Scholar
• Chen WC, Jackson A, Budnick AS, Pfister DG, Kraus DH, Hunt MA, Stambuk H, Levegrun S, Wolden SL. 2006. Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma. Cancer. 106:820–829.
   PubMed Web of Science ®Google Scholar
• Cheraghi S, Nikoofar P, Fadavi P, Bakhshandeh M, Khoie S, Gharehbagh EJ, Farahani S, Mohebbi A, Vasheghani M, Zare M. 2015. Short-term cohort study on sensorineural hearing changes in head and neck radiotherapy. Med Oncol. 32:1–7.
   Web of Science ®Google Scholar
• Daniel WW, Wayne WD. 1995. Biostatistics: a foundation for analysis in the health sciences. New York (NY): John Wiley & Sons; 780pp. ISBN: 0-471-58852-0.
   Google Scholar
• De Marzi L, Feuvret L, Boulé T, Habrand J, Martin F, Calugaru V, Fournier-Bidoz N, Ferrand R, Mazal A. 2015. Use of gEUD for predicting ear and pituitary gland damage following proton and photon radiation therapy. Br J Radiol. 88:20140413.
   PubMed Web of Science ®Google Scholar
• Emami B, Lyman J, Brown A, Cola L, Goitein M, Munzenrider J, Shank B, Solin L, Wesson M. 1991. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 21:109–122.
   PubMed Web of Science ®Google Scholar
• Espenel S, Garcia M-A, Guy J-B, Vallard A, Mrad MB, Langrand-Escure J, Hamrouni AEM, Trone J-C, Xia Y, Rancoule C. 2017. Ototoxicité radio-induite et chimio-induite dans les cancers ORL: de la prévention primaire à la prévention tertiaire. Cancer/Radiothér. 21:77–83.
   Google Scholar
• Fransen E, Lemkens N, Van Laer L, Van Camp G. 2003. Age-related hearing impairment (ARHI): environmental risk factors and genetic prospects. Exp Gerontol. 38:353–359.
   PubMed Web of Science ®Google Scholar
• Gao J, Qian T, Tao C, Zhang Y, Zhou Y, Yang J, He J, Wang R, Zhou P. 2015. SmartArc-based volumetric modulated arc therapy can improve the middle ear, vestibule and cochlea sparing for locoregionally advanced nasopharyngeal carcinoma: a dosimetric comparison with step-and-shoot intensity-modulated radiotherapy. Br J Radiol. 88:20150052.
   PubMed Web of Science ®Google Scholar
• Honoré HB, Bentzen SM, Møller K, Grau C. 2002. Sensori-neural hearing loss after radiotherapy for nasopharyngeal carcinoma: individualized risk estimation. Radiother Oncol. 65:9–16.
   PubMed Web of Science ®Google Scholar
• Houweling AC, Philippens ME, Dijkema T, Roesink JM, Terhaard CH, Schilstra C, Ten Haken RK, Eisbruch A, Raaijmakers CP. 2010. A comparison of dose–response models for the parotid gland in a large group of head-and-neck cancer patients. Int J Radiat Oncol Biol Phys. 76:1259–1265.
   PubMed Web of Science ®Google Scholar
• Huang E, Teh BS, Strother DR, Davis QG, Chiu JK, Lu HH, Carpenter LS, Mai W-Y, Chintagumpala MM, South M. 2002. Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity. Int J Radiat Oncol Biol Phys. 52:599–605.
   PubMed Web of Science ®Google Scholar
• Jackson A, Kutcher G, Yorke E. 1993. Probability of radiation-induced complications for normal tissues with parallel architecture subject to non-uniform irradiation. Med Phys. 20:613–625.
   PubMed Web of Science ®Google Scholar
• Jereczek-Fossa BA, Zarowski A, Milani F, Orecchia R. 2003. Radiotherapy-induced ear toxicity. Cancer Treat Rev. 29:417–430.
   PubMed Web of Science ®Google Scholar
• Källman P, Ågren A, Brahme A. 1992. Tumour and normal tissue responses to fractionated non-uniform dose delivery. Int J Radiat Biol. 62:249–262.
   PubMed Web of Science ®Google Scholar
• Kujawa SG, Liberman MC. 2015. Synaptopathy in the noise-exposed and aging cochlea: primary neural degeneration in acquired sensorineural hearing loss. Hear Res. 330:191–199.
   PubMed Web of Science ®Google Scholar
• Lyman JT. 1985. Complication probability as assessed from dose–volume histograms. Radiat Res. 104:S13–S19.
   Web of Science ®Google Scholar
• Marks LB, Yorke ED, Jackson A, Ten Haken RK, Constine LS, Eisbruch A, Bentzen SM, Nam J, Deasy JO. 2010. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys. 76:S10–S19.
   PubMed Web of Science ®Google Scholar
• Niemierko A, Goitein M. 1993. Modeling of normal tissue response to radiation: the critical volume model. Int J Radiat Oncol Biol Phys. 25:135–145.
   PubMed Web of Science ®Google Scholar
• Niemierko A. 1997. Reporting and analyzing dose distributions: a concept of equivalent uniform dose. Med Phys. 24:103–110.
   PubMed Web of Science ®Google Scholar
• Niemierko A. 1999. A generalized concept of equivalent uniform dose (EUD). Med Phys. 26:1100.
   Google Scholar
• Oh Y-T, Kim C-H, Choi J-H, Kang S-H, Chun M. 2004. Sensory neural hearing loss after concurrent cisplatin and radiation therapy for nasopharyngeal carcinoma. Radiother Oncol. 72:79–82.
   PubMed Web of Science ®Google Scholar
• Rancati T, Fiorino C, Sanguineti G. 2009. NTCP modeling of subacute/late laryngeal edema scored by fiberoptic examination. Int J Radiat Oncol Biol Phys. 75:915–923.
   PubMed Web of Science ®Google Scholar
• Schultheiss TE, Orton CG, Peck R. 1983. Models in radiotherapy: volume effects. Med Phys. 10:410–415.
   PubMed Web of Science ®Google Scholar
• Söhn M, Yan D, Liang J, Meldolesi E, Vargas C, Alber M. 2007. Incidence of late rectal bleeding in high-dose conformal radiotherapy of prostate cancer using equivalent uniform dose-based and dose–volume-based normal tissue complication probability models. Int J Radiat Oncol Biol Phys. 67:1066–1073.
   PubMed Web of Science ®Google Scholar
• Tai A, Wang J, Bao Y, Chen M, Li X. 2012. SU‐C‐BRB‐03: modeling of radiation‐induced sensorineural hearing loss from IMRT and chemotherapy for nasopharyngeal carcinoma. Med Phys. 39:3601.
   Web of Science ®Google Scholar
• US Department of Health and Human Services, National Cancer Institute. 2010. Common terminology criteria for adverse events (CTCAE). 28 May 2009 (v4. 03: 14 June 2010) [last accessed October 2010]. Available from: http.evs.nci.nih.gov/ftp1/CTCAE/About.html
   Google Scholar
• Wong AC, Ryan AF. 2015. Mechanisms of sensorineural cell damage, death and survival in the cochlea. Front Aging Neurosci. 21:58.
   Google Scholar
• Yancey A, Harris MS, Egbelakin A, Gilbert J, Pisoni DB, Renbarger J. 2012. Risk factors for cisplatin-associated ototoxicity in pediatric oncology patients. Pediatr Blood Cancer. 59:144–148.
   PubMed Web of Science ®Google Scholar